Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension

Cirrhotic portal hypertension, the most prevalent and clinically significant complication of liver cirrhosis, manifests as elevated portal venous pressure and is associated with severe complications. Although much research on the mechanisms of portal hypertension has focused on liver fibrosis, less...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanqiu Li, Bingbing Zhu, Ke Shi, Yu Lu, Xuanwei Zeng, Yongqi Li, Qun Zhang, Ying Feng, Xianbo Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1515400/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576381932797952
author Yanqiu Li
Bingbing Zhu
Ke Shi
Yu Lu
Xuanwei Zeng
Yongqi Li
Qun Zhang
Ying Feng
Xianbo Wang
author_facet Yanqiu Li
Bingbing Zhu
Ke Shi
Yu Lu
Xuanwei Zeng
Yongqi Li
Qun Zhang
Ying Feng
Xianbo Wang
author_sort Yanqiu Li
collection DOAJ
description Cirrhotic portal hypertension, the most prevalent and clinically significant complication of liver cirrhosis, manifests as elevated portal venous pressure and is associated with severe complications. Although much research on the mechanisms of portal hypertension has focused on liver fibrosis, less attention has been given to the role of intrahepatic and extrahepatic vascular dysfunction, particularly with respect to extrahepatic vasculature. While the role of hepatic fibrosis in cirrhotic portal hypertension is undeniable, the underlying mechanisms involving intrahepatic and extrahepatic vasculature are highly complex. Sinusoidal capillarization and endothelial dysfunction contribute to increased intrahepatic vascular resistance. Hemodynamic changes in the extrahepatic circulation, including splanchnic vasodilation and hyperdynamic circulation, play a significant role in the development of portal hypertension. Additionally, therapeutic strategies targeting these vascular mechanisms are diverse, including improvement of sinusoidal microcirculation, therapies targeting hepatic stellate cells activation, and pharmacological modulation of systemic vascular tone. Therefore, in this review, we will discuss the vascular-related mechanisms and treatment progress of portal hypertension in cirrhosis to provide a new theoretical basis and practical guidance for clinical treatment.
format Article
id doaj-art-fe544c7081c9432f858bcf84412282db
institution Kabale University
issn 2296-858X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-fe544c7081c9432f858bcf84412282db2025-01-31T06:40:18ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011210.3389/fmed.2025.15154001515400Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertensionYanqiu LiBingbing ZhuKe ShiYu LuXuanwei ZengYongqi LiQun ZhangYing FengXianbo WangCirrhotic portal hypertension, the most prevalent and clinically significant complication of liver cirrhosis, manifests as elevated portal venous pressure and is associated with severe complications. Although much research on the mechanisms of portal hypertension has focused on liver fibrosis, less attention has been given to the role of intrahepatic and extrahepatic vascular dysfunction, particularly with respect to extrahepatic vasculature. While the role of hepatic fibrosis in cirrhotic portal hypertension is undeniable, the underlying mechanisms involving intrahepatic and extrahepatic vasculature are highly complex. Sinusoidal capillarization and endothelial dysfunction contribute to increased intrahepatic vascular resistance. Hemodynamic changes in the extrahepatic circulation, including splanchnic vasodilation and hyperdynamic circulation, play a significant role in the development of portal hypertension. Additionally, therapeutic strategies targeting these vascular mechanisms are diverse, including improvement of sinusoidal microcirculation, therapies targeting hepatic stellate cells activation, and pharmacological modulation of systemic vascular tone. Therefore, in this review, we will discuss the vascular-related mechanisms and treatment progress of portal hypertension in cirrhosis to provide a new theoretical basis and practical guidance for clinical treatment.https://www.frontiersin.org/articles/10.3389/fmed.2025.1515400/fullcirrhotic portal hypertensionsinusoidal capillarizationendothelial dysfunctionsplanchnic vasodilationhyperdynamic circulationnitric oxide
spellingShingle Yanqiu Li
Bingbing Zhu
Ke Shi
Yu Lu
Xuanwei Zeng
Yongqi Li
Qun Zhang
Ying Feng
Xianbo Wang
Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
Frontiers in Medicine
cirrhotic portal hypertension
sinusoidal capillarization
endothelial dysfunction
splanchnic vasodilation
hyperdynamic circulation
nitric oxide
title Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
title_full Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
title_fullStr Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
title_full_unstemmed Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
title_short Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
title_sort advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
topic cirrhotic portal hypertension
sinusoidal capillarization
endothelial dysfunction
splanchnic vasodilation
hyperdynamic circulation
nitric oxide
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1515400/full
work_keys_str_mv AT yanqiuli advancesinintrahepaticandextrahepaticvasculardysregulationsincirrhoticportalhypertension
AT bingbingzhu advancesinintrahepaticandextrahepaticvasculardysregulationsincirrhoticportalhypertension
AT keshi advancesinintrahepaticandextrahepaticvasculardysregulationsincirrhoticportalhypertension
AT yulu advancesinintrahepaticandextrahepaticvasculardysregulationsincirrhoticportalhypertension
AT xuanweizeng advancesinintrahepaticandextrahepaticvasculardysregulationsincirrhoticportalhypertension
AT yongqili advancesinintrahepaticandextrahepaticvasculardysregulationsincirrhoticportalhypertension
AT qunzhang advancesinintrahepaticandextrahepaticvasculardysregulationsincirrhoticportalhypertension
AT yingfeng advancesinintrahepaticandextrahepaticvasculardysregulationsincirrhoticportalhypertension
AT xianbowang advancesinintrahepaticandextrahepaticvasculardysregulationsincirrhoticportalhypertension